RI-MUHC expands recycling to new heights
Impressive cooperation from research programs brings new success to the RI-MUHC waste recycling and sustainability efforts
New advances in lung cancer treatment
International clinical trial shows perioperative immunotherapy prolongs life in non-small-cell lung cancer patients.
New progress in personalizing treatment of sarcoma using AI
RI-MUHC researcher leads the development of the first multimodal deep learning model to optimize care for individual cancer patients
Exponential growth - 2024 Summer student research event hits record-breaking numbers
A record number of presenters representing every research program contributed to a day filled with...
Eight RI-MUHC trainees earn 2024 EDI award for academic excellence
The awards for Equity, Diversity and Inclusion in health care research recognize the academic excellence...
Spring 2024 CIHR competition results
RI-MUHC teams received $17.3 million in project funding
RI-MUHC embraces inclusivity with Duo Emploi Internship Program
For the second year in a row, researchers, trainees and staff welcomed interns with disabilities, fostering an inclusive environment through...
Three RI-MUHC researchers honoured with prestigious Canada Research Chairs
Sylvie Lambert, Marc Martel and Mathieu Roy are emerging leaders in research domains ranging from chronic illnesses...
Triple-negative breast cancer: new hope for an existing drug
RI-MUHC team takes another step toward precision medicine by targeting a biomarker of CDK4/6 inhibitor efficacy in breast cancer, including triple-negative...
Prescribing personalized lifestyle interventions to improve prostate cancer treatments
David Labbé of the RI-MUHC co-leads a new project recently funded by the Marathon of Hope Cancer Centres...